Page last updated: 2024-12-07

pyridoxal 5'-diphospho-5'-adenosine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Pyridoxal 5'-diphospho-5'-adenosine (PLP-Ado) is a coenzyme formed from the reaction of pyridoxal 5'-phosphate (PLP) with adenosine 5'-triphosphate (ATP). It acts as a cofactor for a wide range of enzymatic reactions, particularly those involving amino acid metabolism. PLP-Ado plays a crucial role in the synthesis of neurotransmitters, such as dopamine, serotonin, and norepinephrine, which are essential for brain function and mood regulation. Its importance in these processes makes it a target for research in neurological disorders, such as Parkinson's disease and Alzheimer's disease. PLP-Ado also participates in the synthesis of heme, a component of hemoglobin, which is responsible for oxygen transport in the blood. The study of PLP-Ado aims to understand its role in various metabolic pathways, its contribution to human health, and its potential as a therapeutic target for various diseases.'

pyridoxal 5'-diphospho-5'-adenosine: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID121867
MeSH IDM0138895

Synonyms (14)

Synonym
adenosine diphosphopyridoxal
4500-99-6
[[(2r,3s,4r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] (4-formyl-5-hydroxy-6-methylpyridin-3-yl)methyl hydrogen phosphate
5'-adenosine-5'-diphosphopyridoxal
adp-pyridoxal
unii-il00v5z57e
ap2pl
adenosine 5'-(trihydrogen diphosphate), p'-((4-formyl-5-hydroxy-6-methyl-3-pyridinyl)methyl) ester
pyridoxal 5'-diphospho-5'-adenosine
il00v5z57e ,
pyridoxal-adenine dinucleotide
9-{5-o-[({[(4-formyl-5-hydroxy-6-methylpyridin-3-yl)methoxy](hydroxy)phosphoryl}oxy)(hydroxy)phosphoryl]pentofuranosyl}-9h-purin-6-amine
DTXSID20963320
Q27280773
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (25)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (32.00)18.7374
1990's15 (60.00)18.2507
2000's2 (8.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.11

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.11 (24.57)
Research Supply Index3.26 (2.92)
Research Growth Index4.37 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.11)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (4.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other24 (96.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]